Last reviewed · How we verify
NCT05180331
Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Trial
NA trial testing Mobile Application to Prevent Suicide (MAPS) in Suicide in 10 participants. Completed in 20 May 2024.
20 May 2024
Quick facts
| Lead sponsor | Butler Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 14 December 2023 |
| Primary completion | 20 May 2024 |
| Estimated completion | 20 May 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Mobile Application to Prevent Suicide (MAPS)
Conditions studied
- Suicide — all drugs for Suicide →
- Suicide and Self-harm — all drugs for Suicide and Self-harm →
- Suicide, Attempted — all drugs for Suicide, Attempted →
- Suicidal Ideation — all drugs for Suicidal Ideation →
Sponsor
Butler Hospital
Who can join
Adults 18 to 26, any sex, with Suicide or Suicide and Self-harm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary aim of this grant is to conduct pilot testing on a novel personalized mobile intervention for suicide - Mobile Application to Prevent Suicide (MAPS) - and to establish feasibility, acceptability, safety, and primary outcomes (i.e., suicidal ideation and behavior; re-hospitalization).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Development and Pilot Testing of the Mobile Application to Prevent Suicide (MAPS).
Schatten HT, Hughes CD, Kimble SK, Wallace G, et al · · 2025 · PMID 41725711 · DOI 10.1007/s10608-024-10568-9
Verify or expand the search:
- PubMed search for NCT05180331
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mobile Application to Prevent Suicide (MAPS)
Trials testing the same drug.
- NCT05180344 — Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Tria · NA · recruiting
- NCT05202756 — Examining Feasibility, Acceptability, and Sustainability of a Novel Personalized Smartphone Intervention for Suicide - R · NA · completed
- NCT05180383 — Examining Feasibility, Acceptability, and Sustainability of a Novel Personalized Smartphone Intervention for Suicide - O · NA · completed
Other recruiting trials for Suicide
Currently open trials in the same condition.
- NCT07404787 — Evaluation of a Telehealth Case Management Intervention to Prevent Suicide Among Soldiers Discharged From Psychiatric Ho · NA · recruiting
- NCT07214233 — Youth Empowerment and Safety Intervention · NA · recruiting
- NCT07343258 — Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline · NA · recruiting
- NCT07523490 — Investigation on Suicide Risk Factors of Patients With Mood Disorders · recruiting
- NCT06571916 — Brief Skills for Safer Living (Brief-SfSL) · NA · recruiting
Other Butler Hospital trials
Trials by the same sponsor.
- NCT07404618 — Video Intervention for Older Adults With Chronic Pain · NA · not yet recruiting
- NCT06880796 — Mindfulness-Based Therapy for Serious Mental Illness · NA · enrolling by invitation
- NCT07195019 — Women's Wellbeing Study · NA · recruiting
- NCT06657950 — Treatments for Improving Mood in Women Survivors of Interpersonal Violence: A Community-Engaged Study-1.2 · NA · completed
- NCT05180344 — Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Tria · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05180331 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Butler Hospital
- Last refreshed: 19 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05180331.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing